静脉注射免疫球蛋白对川崎病患儿中性粒细胞的影响

摘要
图/表
参考文献(10)
相关文章 (15)
点击分布统计
下载分布统计

	［1］Ayusawa M, Sonobe T, Uemura S, Nakamura Y, Ogawa S, Kiyosawa N. Revision of diagnostic guidelines for Kawasaki disease(the 5th revised edition)［J］. Pediatr Int, 2005, 47(2): 232-234.
	［2］Esper F, Shapiro ED, Weibel C, Ferguson D, Landry ML, Kahn JS. Association between a novel human coronavirus and Kawasaki disease［J］. J Infect Dis, 2005, 191(4): 499-502.
	［3］Yeung RSM. The etiology of Kawasaki disease: a superantigen-mediated process［J］. Prog Pediatr Cardiol, 2004, 19(2): 115-122.
	［4］Yeung RS. Pathogenesis and treatment of Kawasaki's disease［J］. Curr Opin Rheumatol, 2005, 17(5): 617-623.
	［5］胡景伟，杨凌，郑承宁，王琨蒂，王萍，周忠蜀.川崎病并发冠状动脉病变的临床特点［J］.中国当代儿科杂志，2010，12（3）：228-230.
	［6］Lin CY, Lin CC, Hwang B, Chiang B. Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease［J］. J Pediatr, 1992, 121(6): 924-926.
	［7］Igarashi H, Hatake K, Tomizuka H, Yamada M, Gunji Y, Momoi MY. High serum level of M-CSF and G-CSF in Kawasaki disease［J］. Br J Hematol, 1999, 105(3): 613-615.
	［8］Suzuki H, Noda E, Miyawaki M, Takeuchi T, Uemura S, Koike M. Serum levels of neutrophil activation cytokines in Kawasaki disease［J］.Pediatr Int, 2001, 43(2): 115-119.
	［9］Onouchi Z, Hamaoka K, Ozawa S, Sakata K, Kiyosawa N, Ito H. Neutropenia in the acute phase of Kawasaki disease and prevention of coronary artery aneurysm［J］. Pediatr Int, 2009, 51(4): 448-452.
	［10］Tsujimoto H, Takeshita S, Nakatani K, Kawamura Y, Tokutomi T, Sekine I.Intravenous immunoglobulin therapy induces neutrophil apoptosis in Kawasaki disease［J］.Clin Immunol, 2002,103(2): 161-168.